butyl-3'-(1H-tetrazol-5-yl)oxanilate,
tazanolast,
tazanolast,
82989-25-1,
Butyl 2-((3-(1H-tetrazol-5-yl)phenyl)amino)-2-oxoacetate,
Tazanolast [INN:JAN],
Tazanolastum [INN-Latin],
WP-833,
5-(3-n-Butyloxalylaminophenyl)tetrazole,
UNII-T0248823H1,
Butyl 3'-(1H-tetrazol-5-yl)oxanilate,
CHEMBL564109,
oxo[[3-(1h-tetrazol-5-yl)phenyl]amino]acetic acid butyl ester,
C13H15N5O3,
NCGC00183655-01,
Oxo((3-(1H-tetrazol-5-yl)phenyl)amino)acetic acid butyl ester,
T0248823H1,
butyl 2-oxo-2-[3-(2H-tetrazol-5-yl)anilino]acetate,
Tazanolastum,
Tazalest,
Tazanol,
Acetic acid, oxo((3-(1H-tetrazol-5-yl)phenyl)amino)-, butyl ester,
Tazanol (TN),
Tazanolast (JAN/INN),
AC1Q66UF,
DSSTox_CID_28552,
DSSTox_RID_82824,
DSSTox_GSID_48626,
SCHEMBL28495,
AC1L1K85,
DTXSID6048626,
CHEBI:32183,
CTK5F0260,
XQTARQNQIVVBRX-UHFFFAOYSA-N,
ZINC1548562,
Tox21_112967,
BDBM50295559,
AKOS016013960,
AN-5710,
API0004328,
CS-6660,
K481,
LS-12662,
AX8152431,
CAS-82989-25-1,
HY-101810,
FT-0630915,
D01669,
butyl 2-(3-(1H-tetrazol-5-yl)phenylamino)-2-oxoacetate,
butyl 2-(3-(2H-tetrazol-5-yl)phenylamino)-2-oxoacetate,
CID5380,
AR-1K9419,
C13-H15-N5-O3,
MTB,
Butyl2-((3-(1H-tetrazol-5-yl)phenyl)amino)-2-oxoacetate,
6961-62-2,